As liver cancer rates surge, advances in treatment bring hope | Hub
Medical researchers at Johns Hopkins aim to accelerate therapies that improve and save lives as liver cancer becomes one of the most common cancers in the U.S.| The Hub
The Gilbert Family Foundation awarded an $8 million grant to Children’s National to accelerate research on neurofibromatosis type 1 (NF1). The post Advancing innovative treatments for neurofibromatosis type 1 appeared first on Innovation District.| Innovation District
Medical researchers at Johns Hopkins aim to accelerate therapies that improve and save lives as liver cancer becomes one of the most common cancers in the U.S.| The Hub
Under new $2.6 million NIH grant MBI researchers will investigate why some patients respond to dendritic cell therapy and some do not.| McKnight Brain Institute » University of Florida
The German biotech ecosystem is well established despite the challenges it is facing. Discover fourteen key Germany-based biotech companies.| Labiotech.eu
A phase 2 study reveals autologous TIL therapy's potential to stabilize recurrent head and neck cancer, offering hope for improved treatment options.| www.targetedonc.com
It started with wine. Or more precisely, a conversation about it. “My colleagues and I were talking about how some ...Read More The post A toast to BRD4: How acidity changes the immune response appeared first on Boston Children's Answers.| Boston Children's Answers
Federal budget cuts have created "a climate of anxiety" among medical researchers, says Maximilian F. Konig, a rheumatologist at Johns Hopkins. But those who live with autoimmune diseases could suffer the greatest consequences.| The Hub
Telomere damage drives T cell exhaustion. Antioxidants restored their cancer-fighting strength in mice. Tumor environments place heavy stress on immune cells that fight cancer. Limited oxygen, elevated acidity, and other harsh conditions overload mitochondria, the cell’s energy producers, which c| SciTechDaily
Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to one day become a universal cancer treatment. But there are risks. Similarities between cancerous and healthy cells can affect the body’s immune response, causing T cells to attack unintended targets. TCR therapy needs... The post BATMAN brings TCR therapy out of the shadows appeared first on Cold Spring Harbor Laboratory.| Cold Spring Harbor Laboratory
Bispecific antibodies are a rapidly advancing class of therapeutics, offering a new level of precision in treating diseases like cancer.| Drug Discovery and Development
Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly skin cancer.| Labiotech.eu
One dose of a new treatment, delivered by nasal spray, clears away build-ups of the toxic tau protein associated with Alzheimer’s disease from inside brain cells, improving memory, according to new research. It paves the way for new treatments for the debilitating disease.| New Atlas
Introduction – World Brain Tumor Day will be celebrated annually on June 8 across the world to raise awareness about the harmful effects of brain tumors and also provide support to those patie…| daneelyunus
Representing the creative, outside-the-box thinking done by the program’s namesake, two College of Medicine members received the 2025 Thomas H. Maren Research Excellence Award for their innovative biomedical ideas.| research.med.ufl.edu
Investigators from Nationwide Children’s Hospital created fratricide-resistant and metabolically-enhanced chimeric antigen receptor (CAR) natural killer (NK) and T cells that have cytotoxic effects on many hematologic tumors.| Pediatrics Nationwide
When Siana learned she had breast cancer, her world stopped. She was angry and scared, but realized she needed to focus on the positive.| Susan G. Komen®
Skin prick allergy testing requires specialized training to administer and interpret the tests and determine appropriate treatment.| Allergy & Asthma Network
The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease?| Labiotech.eu
A new oral desensitization treatment for children with peanut allergies is on the cusp of FDA approval, however questions remain over both the long-term efficacy of the treatment and the ultimate cost for something that is essentially not much different to peanut flour in a capsule.| New Atlas
On its way to tackle cancer therapy resistance with its monoclonal antibody visugromab, CataLym completes a $150 million series D round.| Labiotech.eu
Carolina researchers are using CAR-T cells to create better and personalized cancer treatments in one of the largest cell therapy facilities on the East Coast.| UNC Research Stories
